WeVote
Log In

Bill

Bill

HB 2412

Relating to health benefit plan coverage for certain obesity medications.

89th Legislature (2025) Introduced by John Bucy

Texas bill mandates health insurance coverage for select obesity medications to increase patient access to GLP-1 treatments currently limited by cost and insurer restrictions.

Referred to Insurance
#health--otherdiseases&medicalconditions(i0383) #humanservices--medicalassistance(i0905) #insurance--health&accident(i0422) #retirementsystems--stateemployees(i0727) #retirementsystems--teachers(i0726)
0
WeVote Research Nonpartisan
Bill Summary · HB 2412

Legislative bill overview

HB 2412 would require health benefit plans in Texas to cover certain obesity medications, likely including GLP-1 receptor agonists (such as semaglutide and tirzepatide). The bill aims to expand insurance coverage for pharmaceutical treatment of obesity, which is currently often denied or limited by many insurers.

Why is this important

Obesity affects millions of Texans and contributes to serious health conditions like diabetes, heart disease, and certain cancers. Prescription obesity medications have demonstrated clinical effectiveness but remain expensive and inaccessible to many people without insurance coverage, creating a significant barrier to treatment for lower-income populations.

Potential points of contention

  • Cost implications: Mandatory coverage of these medications could increase insurance premiums or reduce insurer profitability, potentially raising healthcare costs for all consumers
  • Medical necessity debate: Some argue obesity medications should be prescribed only for specific clinical conditions rather than covered universally, questioning whether this represents appropriate medical gatekeeping or necessary cost control
  • Supply chain concerns: Expanded demand for obesity medications could exacerbate existing shortages, potentially affecting patients with diabetes who also rely on these drugs
  • Scope ambiguity: The bill's language about "certain obesity medications" is vague—it's unclear which specific drugs would be covered or what eligibility criteria patients must meet

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.